Literature DB >> 22389416

Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction.

Nicolas Clementy1, Bertrand Pierre, Bénédicte Lallemand, Olivier Marie, Eric Lemoine, Pierre Cosnay, Laurent Fauchier, Dominique Babuty.   

Abstract

AIMS: Implantable cardioverter defibrillators (ICDs) are efficient in reducing mortality in patients with left ventricular systolic dysfunction. High-rate cut-off programming may be effective in reducing appropriate and inappropriate therapies, but as the long-term consequences on morbidity and mortality remain unclear, it is underutilized. METHODS AND
RESULTS: We prospectively studied 365 consecutive patients (mean age 60 ± 10 years), with ischaemic (63%) or non-ischaemic cardiomyopathy and left ventricular dysfunction (mean ejection fraction 25 ± 7%), who were implanted with an ICD in primary prevention of sudden cardiac death (41% single chamber, 31% dual chamber, and 28% biventricular). All devices were programmed with a shock-only zone over 220 beats per minute (b.p.m.) and a monitoring zone between 170 and 220 b.p.m. During a median follow-up of 40 months, 41 patients received appropriate shocks (11.2%) and 24 inappropriate shocks (6.6%). Then, 306 patients never experienced any ICD shock (84%). Inappropriate discharges were related to supraventricular tachyarrhythmia in 10 patients, and noise/oversensing in 14 patients. Ventricular tachycardia episodes, sustained or not, were recorded in the monitoring zone in 43 patients (11.8%). Seven of these patients were symptomatic (1.9%), without lethal consequence. Sixty-two patients (17%) died: 35 from end-stage heart failure, 1 from unexplained sudden death, and 26 from a documented non-cardiac cause.
CONCLUSION: High-rate cut-off (220 b.p.m.) shock-only ICD programming, in primary prevention patients with reduced left ventricular ejection fraction, appeared to be safe during a long-term follow-up. It also resulted in a very low rate of discharges, which are known to be deleterious in this population.

Entities:  

Mesh:

Year:  2012        PMID: 22389416     DOI: 10.1093/europace/eus028

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  8 in total

1.  Reduction of inappropriate implantable cardioverter-defibrillator therapies using enhanced supraventricular tachycardia discriminators: the ReduceIT study.

Authors:  Johann Christoph Geller; Armin Wöhrle; Mathias Busch; Albrecht Elsässer; Thomas Kleemann; Frank Birkenhauer; Peter Bramlage; Christian Veltmann
Journal:  J Interv Card Electrophysiol       Date:  2020-07-14       Impact factor: 1.900

Review 2.  ICD programming.

Authors:  Mauro Biffi
Journal:  Indian Heart J       Date:  2013-12-20

3.  [Inappropriate ICD therapies: All problems solved with MADIT-RIT?].

Authors:  Christof Kolb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-04-21

4.  "Carryover phenomenon" in subcutaneous implantable cardioverter-defibrillator: Residual energy caused early shock to subsequent ventricular tachycardia.

Authors:  Yasunobu Yamagishi; Yasushi Oginosawa; Keishiro Yagyu; Taro Miyamoto; Tsukahara Keita
Journal:  J Arrhythm       Date:  2022-04-05

5.  Relation between detection rate and inappropriate shocks in single versus dual chamber cardioverter-defibrillator--an analysis from the OPTION trial.

Authors:  Christof Kolb; Marcio Sturmer; Dominique Babuty; Peter Sick; Jean Marc Davy; Giulio Molon; Jörg Otto Schwab; Giuseppe Mantovani; Andrew Wickliffe; Carsten Lennerz; Verena Semmler; Pierre-Henri Siot; Sebastian Reif
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

6.  2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

Authors:  Bruce L Wilkoff; Laurent Fauchier; Martin K Stiles; Carlos A Morillo; Sana M Al-Khatib; Jesœs Almendral; Luis Aguinaga; Ronald D Berger; Alejandro Cuesta; James P Daubert; Sergio Dubner; Kenneth A Ellenbogen; N A Mark Estes; Guilherme Fenelon; Fermin C Garcia; Maurizio Gasparini; David E Haines; Jeff S Healey; Jodie L Hurtwitz; Roberto Keegan; Christof Kolb; Karl-Heinz Kuck; Germanas Marinskis; Martino Martinelli; Mark McGuire; Luis G Molina; Ken Okumura; Alessandro Proclemer; Andrea M Russo; Jagmeet P Singh; Charles D Swerdlow; Wee Siong Teo; William Uribe; Sami Viskin; Chun-Chieh Wang; Shu Zhang
Journal:  J Arrhythm       Date:  2016-02-01

7.  Prognostic Importance of Defibrillator-Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart Failure.

Authors:  Yitschak Biton; Usama A Daimee; Jayson R Baman; Valentina Kutyifa; Scott McNitt; Bronislava Polonsky; Wojciech Zareba; Ilan Goldenberg
Journal:  J Am Heart Assoc       Date:  2019-03-19       Impact factor: 5.501

Review 8.  The Defibrillation Conundrum: New Insights into the Mechanisms of Shock-Related Myocardial Injury Sustained from a Life-Saving Therapy.

Authors:  Nicolas Clementy; Alexandre Bodin; Arnaud Bisson; Ana-Paula Teixeira-Gomes; Sebastien Roger; Denis Angoulvant; Valérie Labas; Dominique Babuty
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.